Morten Harket of A-ha Reveals Parkinson’s Diagnosis

Morten Harket, the renowned frontman of the iconic Norwegian band A-ha, has publicly shared his Parkinson’s disease diagnosis, a revelation that has gripped fans worldwide. This news was disseminated through multiple media outlets on June 4, 2025, marking a significant moment both for Harket and the global music community. The diagnosis, though challenging, offers a glimpse into the personal battles faced by the vocalist known for his striking voice and charismatic stage presence, especially as he acknowledges the profound impact the disease may have on his ability to continue performing.

Parkinson’s disease, a progressive neurological condition that gradually impairs movement and causes tremors, has affected Harket’s motor skills and, significantly, his vocal capabilities. According to the Mayo Clinic, where Harket received treatment, the disease is a disorder of the nervous system, getting progressively worse over time. Harket has undergone two critical neurosurgeries to implant electrodes in his brain, aimed at reducing the symptoms of the disease. These operations, performed in June and December 2024, have reportedly led to some improvement in his symptoms, allowing him to manage his condition more effectively, albeit with some limitations.

For Harket, the journey with Parkinson’s has been described as a “never-ending rollercoaster ride,” a sentiment reflective of the daily challenges he faces. Despite therapeutic advancements, the illness has had a detrimental impact on his voice, a development Harket finds particularly troubling given his illustrious career dominated by herculean vocal performances in hits like “Take On Me.” The neurosurgeries, known as deep brain stimulation (DBS), aim to alleviate the physical symptoms; however, Harket admits he still struggles with singing, indicating that the disease has brought uncertainty about his future in music. He emphasizes that while singing is a significant part of his life, it’s not the entirety of his identity, suggesting that he might explore other pursuits and priorities beyond music.

In sharing his diagnosis, Harket expressed the initial hesitance he felt about going public, concerned about the privacy of his condition and the inevitable deluge of advice and sympathy from well-meaning fans. He acknowledges that managing both the disease and public perception is a complex task, requiring a balance of medication and lifestyle adjustments under the guidance of medical professionals. Despite the personal and professional challenges posed by Parkinson’s, Harket remains focused on maintaining his health and exploring other aspects of creativity, illustrating resilience amidst adversity.

The global community and music fans, while concerned, have been asked by Harket to direct their energy towards tackling substantive global issues, highlighting his environmental advocacy and urging fans to engage in actions beneficial to the planet. His message underscores a commitment to living purposefully, even while grappling with such a life-altering diagnosis. Harket’s open dialogue about his experience with Parkinson’s also serves to shine a light on the widespread need for increased awareness and research surrounding the disease, which affects millions worldwide.

Morten Harket’s public acknowledgment of his condition is not just a personal unveiling but a testament to his enduring commitment to his craft and fans. His decision to confront Parkinson’s openly may inspire others battling similar challenges to speak out and seek support. As A-ha’s legacy continues to thrive, Morten Harket’s journey with Parkinson’s adds a profound chapter to the band’s narrative, celebrated not only for its timeless music but also for its frontman’s bravery and candor in the face of personal trials.